{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:13:07Z","timestamp":1786993987363,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.mayocp.2019.03.033","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T09:55:37Z","timestamp":1571824537000},"page":"2189-2198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort"],"prefix":"10.1016","volume":"94","author":[{"given":"Shravya","family":"Vinnakota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Rodeheffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2019.03.033_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrneph.2013.260","article-title":"Cardiovascular disease in CKD in 2013: Reducing cardiovascular risk--light at the end of the tunnel","volume":"10","author":"Kendrick","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"9889","key":"10.1016\/j.mayocp.2019.03.033_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.mayocp.2019.03.033_bib3","first-page":"2918","article-title":"Cardiovascular disease and its relationship with chronic kidney disease","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.mayocp.2019.03.033_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ypmed.2016.06.004","article-title":"Role of renal function in cardiovascular risk assessment: a retrospective cohort study in a population with low incidence of coronary heart disease","volume":"89","author":"Garcia-Gil","year":"2016","journal-title":"Prev Med"},{"issue":"9","key":"10.1016\/j.mayocp.2019.03.033_bib5","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.amjmed.2015.03.024","article-title":"Estimated glomerular filtration rate within the normal or mildly impaired range and incident cardiovascular disease","volume":"128","author":"Eisen","year":"2015","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2019.03.033_bib6","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/ATVBAHA.114.303465","article-title":"Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study","volume":"34","author":"Matsushita","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.03.033_bib7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1053\/j.ajkd.2005.06.017","article-title":"B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy","volume":"46","author":"Vickery","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4-5","key":"10.1016\/j.mayocp.2019.03.033_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinbiochem.2015.01.008","article-title":"High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease","volume":"48","author":"Bjurman","year":"2015","journal-title":"Clini Biochem"},{"issue":"7","key":"10.1016\/j.mayocp.2019.03.033_bib9","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1681\/ASN.2008090954","article-title":"Association of preventive health care with atherosclerotic heart disease and mortality in CKD","volume":"20","author":"Snyder","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.03.033_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2019.03.033_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2019.03.033_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mayocp.2019.03.033_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.mayocp.2016.02.026","article-title":"The natural history of patients with isolated metabolic syndrome","volume":"91","author":"Patel","year":"2016","journal-title":"Mayo Clinic Proc"},{"issue":"8","key":"10.1016\/j.mayocp.2019.03.033_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"issue":"2-3","key":"10.1016\/j.mayocp.2019.03.033_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijcard.2003.06.005","article-title":"Impaired left ventricular diastolic function during isometric exercise in asymptomatic patients with hyperlipidaemia","volume":"95","author":"Salmasi","year":"2004","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","author":"Contal","year":"1999","journal-title":"Comput Stat Data An"},{"issue":"17","key":"10.1016\/j.mayocp.2019.03.033_bib17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNH.0b013e328337bba7","article-title":"Temporal trends in the burden of chronic kidney disease in the United States","volume":"19","author":"Foley","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7","key":"10.1016\/j.mayocp.2019.03.033_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7326\/M16-0273","article-title":"Trends in Prevalence of Chronic Kidney Disease in the United States","volume":"165","author":"Murphy","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MNH.0000000000000315","article-title":"Recent trends in the prevalence of chronic kidney disease: not the same old song","volume":"26","author":"Hsu","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"10.1016\/j.mayocp.2019.03.033_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/76.11.1111","article-title":"Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling","volume":"76","author":"Cataliotti","year":"2001","journal-title":"Mayo Clinic Proc"},{"issue":"10","key":"10.1016\/j.mayocp.2019.03.033_bib22","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2008.11.031","article-title":"Does renal clearance differ between the B-type natriuretic peptides (BNP versus NT-proBNP)?","volume":"53","author":"Palmer","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.03.033_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1309\/AJCP60HTPGIGFCNK","article-title":"The effect of renal dysfunction on BNP, NT-proBNP, and their ratio","volume":"133","author":"Srisawasdi","year":"2010","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.03.033_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/clinchem\/46.3.338","article-title":"Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology","volume":"46","author":"Ooi","year":"2000","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.mayocp.2019.03.033_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/M14-0743","article-title":"Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis","volume":"161","author":"Michos","year":"2014","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2019.03.033_bib27","article-title":"Effect modification of chronic kidney disease on the association of circulating and imaging cardiac biomarkers with outcomes","volume":"6","author":"Gregg","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.mayocp.2019.03.033_bib28","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0735-1097(03)00787-3","article-title":"Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath","volume":"42","author":"Lainchbury","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib29","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2215\/CJN.03600414","article-title":"Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD","volume":"10","author":"Colbert","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.03.033_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/eurjhf\/hfs049","article-title":"Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study","volume":"14","author":"Cleland","year":"2012","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.mayocp.2019.03.033_bib31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1681\/ASN.2014010108","article-title":"High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"26","author":"Bansal","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.03.033_bib32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.amjcard.2012.10.019","article-title":"Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC])","volume":"111","author":"Mishra","year":"2013","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.mayocp.2019.03.033_bib33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2019.03.033_bib34","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrneph.2014.242","article-title":"Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes","volume":"11","author":"Sarafidis","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"9731","key":"10.1016\/j.mayocp.2019.03.033_bib35","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.mayocp.2019.03.033_bib36","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1161\/CIRCULATIONAHA.107.724187","article-title":"N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK)","volume":"117","author":"Astor","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2019.03.033_bib37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0735-1097(17)34319-X","article-title":"Neurohumoral activation and long-term cardiovascular outcomes in chronic kidney disease: a population-based cohort","volume":"69","author":"Vinnakota","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961930415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561961930415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:43Z","timestamp":1758418303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561961930415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S002561961930415X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.03.033","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}